Your session is about to expire
← Back to Search
Transcranial direct current stimulation (tDCS) for Depression
Study Summary
This trial will test whether a single session of transcranial direct current stimulation (tDCS) to the dorsolateral prefrontal cortex (DLPFC) can reduce depression-related attention bias in patients with mild to moderate depression.
- Depression
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a history of seizures that are not well controlled.You are currently struggling with drug or alcohol addiction.You are pregnant or breastfeeding.You have had a head injury within the past year.You are a female.You have implants in your head or neck.Depression that is not severe, as judged by how low the person's BDI-II score is.If you are taking antidepressants, your medication must be stable for 30 days prior to screening.You have a neurological condition that makes it impossible for you to participate in the study, as determined by the study clinician.You have a skin condition or sensitive skin in areas where the study treatment will be applied or administered.
- Group 1: Female participants with Depression
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there opportunities available for individuals to enroll in this trial?
"Affirmative, the details on clinicaltrials.gov confirm that recruitment for this trial has commenced. This study was first listed on December 15th 2021 and revised as recently as November 22nd 2022. 75 patients are currently being enrolled at a single site."
Does this research endeavor solicit individuals aged sixty and over?
"To be eligible for this study, the patient must fall between 18 to 45 years old. For those under 18 or over 65, there are 192 and 963 trials respectively that may fit their criteria."
How many participants has this clinical trial recruited thus far?
"Affirmative. According to details found on clinicaltrials.gov, enrollment for this medical trial is currently underway. It was originally posted on December 15th 2021 and underwent its most recent update November 22nd 2022. The research requires 75 participants from a single location of study."
Who would be the ideal candidate to partake in this research endeavor?
"This investigation is recruiting 75 participants with depression, aged 18-45. Prerequisites for enrollment include being female and having moderately significant to severe symptoms as indicated by BDI-II scores between 14-19 or 20-28 if on stable pharmalogic medication at least 30 days prior to screening."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- NYU Langone Health: < 48 hours
Average response time
- < 2 Days
Share this study with friends
Copy Link
Messenger